Friday - March 29, 2024
Perelman School of Medicine: Newly Discovered Brain Response to Obesity Drug May Inform Future Treatments
March 05, 2020
PHILADELPHIA, Pennsylvania, March 5 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:

* * *

- Penn researchers show how FDA-approved drug interacts with distinct set of neurons in the brain's "energy balance" system

* * *

The U.S. Food and Drug Administration-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite. H . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products